(Q42984882)

12 November 2017

title

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response? (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Richard K Sterling

1

1 reference

12 November 2017

Charlotte M Hofmann

2

1 reference

12 November 2017

Velimir A Luketic

3

1 reference

12 November 2017

Arun J Sanyal

4

1 reference

12 November 2017

Melissa J Contos

5

1 reference

12 November 2017

A Scott Mills

6

1 reference

12 November 2017

Mitchell L Shiffman

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

The American Journal of Gastroenterology

12 November 2017

published in

1 reference

12 November 2017

volume

99

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

866-872

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Hepatitis C in state correctional facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

A survey of bloodborne viruses and associated risk behaviours in Greek prisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Hepatitis C and the correctional population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Treating histologically mild chronic hepatitis C: monotherapy, combination therapy, or tincture of time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Treatment of chronic hepatitis C in a state correctional facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30310.X

10.1111/J.1572-0241.2004.30310.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference